Supplementary Figure 1 from Unraveling the Tumor Microenvironment and PD-L1 Expression across Tissue Types in High-Grade Serous Ovarian Cancer in the NeoPembrOV/GINECO Phase II Randomized Trial

Key Points

MAIN FINDING: The study highlights the role of pd-l1 in the tumor microenvironment of ovarian cancer.
KEY EVIDENCE: Analyzed biomarkers indicate variations in pd-l1 expression across different tissue types.
APPROACH: Utilized data from the neoPembrOV/GINECO Phase II randomized trial to examine patient populations.
SIGNIFICANCE: Findings inform treatment strategies and improve understanding of tumor behavior in ovarian cancer.

We only have this paper's title and publication details.

This randomized trial examines pd-l1 expression and biomarkers in high-grade serous ovarian cancer, revealing insights into tumor microenvironment.

Supplementary Figure 1. Flow chart of the population and biomarkers analyses.

No takes yet. Share an insight, caveat, or question.

Collet et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Share